Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$91,614,272
+$65,616,144 QoQ
Shares Held
1,230,052
+251.3% QoQ
Ownership
0.629%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#39
of 472 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Dec 31, 2025CallValue
$6,975,888
CallShares
91,200
PutValue
$940,827
PutShares
12,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. BBIO ranks #3 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in BBIO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,614,272 | 1,230,052 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,998,128 | 350,096 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $940,827 | 12,300 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $17,928,414 | 234,389 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $6,975,888 | 91,200 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $638,862 | 12,300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $52,702,323 | 1,014,677 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $5,375,790 | 103,500 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $3,851,656 | 89,200 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $548,386 | 12,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $70,885,151 | 1,641,620 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $439,039 | 12,700 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $27,658,592 | 800,075 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $670,658 | 19,400 | Call | Sole | 2025-05-15 | |
| 2024-09-30 | $504,108 | 19,800 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $1,779,654 | 69,900 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $13,208,800 | 518,806 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,250,402 | 207,280 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $3,649,092 | 220,090 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $248,500 | 25,000 | Call | Sole | 2022-11-15 | |
| 2022-03-31 | $373,377 | 36,786 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $812,316 | 48,700 | Call | Sole | 2022-02-14 | |
| 2020-12-31 | $3,555,500 | 50,000 | Call | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||